Preliminary findings suggest that some cell therapies may be relatively safe and effective, but larger double-blinded placebo-controlled studies are needed to establish the long-term risks and benefits.
Browsing: Journal Articles
This article discusses two potential neural networks, the serotonergic system and the OTergic system, that could prove to be particularly useful targets for endocrine therapy.
This systematic review provides a summary of the blood protein biomarkers that have been studied for the diagnosis of acute ischemic stroke.
A biomarker to aid in the diagnosis of ischemic stroke and its causes would be of value in acute clinical practice. It could have applications to aid in acute stroke treatment decisions for tissue plasminogen activator and/or the triage to endovascular therapy. This review provides an overview of RNA as a novel biomarker for the diagnosis and assessment of ischemic stroke.
This communication examines the association between the number of seizures in refractory epileptic patients and potential interactions between their antiepileptic medications and single nucleotide polymorphisms.
The goal of this study was to test the state of methylation of transcription start positions in DNA that are actively involved in transcription.
This study generates a novel dataset of associations for disorders such as major depression and schizophrenia, providing a global perspective for their genetic etiology.
This Review looks at the literature surrounding recent neurophysiological techniques and novel surgical tools in pediatric epilepsy.
This Editorial explores the potential use of biomarkers such as TGF-β, neurofilament light polypeptide, autotaxin, α-syn and complement for AD diagnosis.
The hypothesis that antidepressant response has a relevant genetic component was initially suggested by the observation that this phenotype clusters in families.